Pharmaceuticals Financial News

Drugmakers kicked off 2024 by raising the list prices for Ozempic, Mounjaro and dozens of other widely used medicines. Companies including Novo Nordisk, the maker of Ozempic, and Eli Lilly, which sells Mounjaro, raised list prices on 775 brand-name drugs during the first half of January, according to an analysis for The Wall Street Journal by 46brooklyn Research, a nonprofit drug-pricing analytics group. The drugmakers raised prices of their medicines by a median of 4.5%, though the prices of some drugs rose by around 10% or higher, according to the research group.

Shares of Biocon Ltd.(up 2.32 per cent) and Alkem Laboratories Ltd.(up 0.46 per cent) ended the day as top gainers in the pack. On the other hand, Aurobindo Pharma Ltd.(down 2.68 per cent), Divi's Laboratories Ltd.(down 2.44 per cent), Glenmark Pharmaceuticals Ltd.(down 2.34 per cent), Pfizer Ltd.(down 2.11 per cent) and Natco Pharma Ltd.(down 1.97 per cent) finished as the top losers of the day.

Shares of Aurobindo Pharma Ltd.(up 5.01 per cent), Granules India Ltd.(up 4.85 per cent), Glenmark Pharmaceuticals Ltd.(up 4.78 per cent), Biocon Ltd.(up 2.52 per cent) and Zydus Lifesciences Ltd.(up 1.84 per cent) ended the day as top gainers in the pack. On the other hand, Sanofi India Ltd.(down 1.83 per cent), Gland Pharma Ltd.(down 0.69 per cent), Natco Pharma Ltd.(down 0.43 per cent) and Alkem Laboratories Ltd.(down 0.22 per cent) finished as the top losers of the day.

J.B. Chemicals & Pharmaceuticals share price has seen more than 70% gains during last one year. J.B.

Antidepressants and mood elevators are among the highest-sold medicine categories as the country's youth increasingly seek help for mental health disorders. One upside is that Gen Z do not consider it a taboo to seek psychological help, experts say. Consider this.

Lupin announced on Sunday, January 14, that it has received approval from the US health regulator to market a generic drug to treat migraine and hypertension. The Mumbai-based company has received the nod from the US Food and Drug Administration (USFDA) for Propranolol Hydrochloride extended-release capsules in multiple strengths, said Lupin Ltd in a regulatory filing to the stock exchanges today. The company's product is the generic version of ANI Pharmaceuticals' Inderal LA extended-release capsules, it added.

Investing.com – Israel stocks were lower after the close on Sunday, as losses in the Biomed, Communication and Real Estate sectors led shares lower.

bilateral initiatives aimed at further strengthening the seamless cross-border connectivity, as the officials from the two sides met to discuss ways to fortify the economic and commercial linkages. The India-Nepal Inter-Governmental Sub-Committee (IGSC) on Trade, Transit, and Cooperation to Combat Unauthorised Trade convened its latest session in Kathmandu on January 12-13.

While the headlines are occupied with the wedding of Bollywood superstar Aamir Khan’s daughter Ira Khan to her beau Nupur Shikhare, another high-profile couple is also preparing for their big day! The wedding bells are ringing for Anant Ambani( the youngest son of Reliance Industries Chairman Mukesh Ambani and his wife Nita) and his fiance Radhika Merchant. While not many details are known about their upcoming wedding, details about their wedding invitation card have gone viral on the Internet. The card which includes a handwritten note by the Ambanis, reads, “We are thrilled to invite you to Radhika and Anant’s pre-wedding festivities at the Reliance Greens in Jamnagar, from March 1-3 2024. With the blessings of Smt Kokilaben & Shri Dhirubhai Ambani, Smt. Purnimaben & Shri Ravindrabhai Dalal we are delighted to invite you to the pre-wedding celebrations of our son." The note also added a detailed history of Jamnagar. Established in 1997, it soon developed into the world’s largest grassroot refining complex. The proud parents also wrote about how their son Anant had transformed the complex into a haven for rescued animals. The couple then invited the guests to attend the wedding and shower blessings on the couple. Radhika and Anant have known each other for quite a few years. The pair got engaged in 2022 at the Ambani residence in Antilia in Mumbai in a traditional Gujarati ceremony, that consisted of rituals such as Gol Dhana, Chunari Vidhi etc.

Zerodha CEO Nithin Kamath sets himself a new fitness goal every quarter — it could be something to do with long-distance running or swimming, the idea is to keep things interesting. “Productivity at work is directly proportional to your quality of health,” he said. “If your body is healthy, your outcome at work will be better.” Emcure Pharmaceuticals executive director Namita Thapar agreed. “I strongly believe in the link between health and work productivity,” she said. “Yoga has been a gamechanger for me. The asanas and breathing have made me a kinder and more focused leader.”

NEW DELHI : Antibiotics routinely prescribed to treat common ailments no longer work as bacteria have developed resistance to these drugs due to their overuse in India, a government body said, echoing concerns long voiced by international experts. In a report, the National Centre for Disease Control (NCDC) mentioned about third-generation cephalosporins, imidazoles, amino-glycosides, ceftriaxone, metronidazole, amikacin and piperacillin, which are used to treat cold, fever, skin diseases and urinary tract infection. Companies that make these antibiotics in India include Alkem Laboratories Ltd, Mankind Pharma Ltd, Zuventus Healthcare Ltd, Cadila Pharmaceuticals Ltd, Surya Pharmaceutical Ltd, Aristo Pharmaceuticals Pvt.

Stock market today: Shares of Evoq Remedies Ltd are one of the small-cap stocks that are priced below ₹50 in the Indian stock market. The small-cap stock below ₹50 has informed Indian exchanges that it has received an export order worth ₹136 crore, which has attracted the attention of market investors. The pharma stock informed BSE about the export order on Wednesday and the stock immediately touched the 20 per cent upper circuit after the outbreak of this stock market news.

Also read- Polycab India share price cracks 20% to hit lower circuit on reports of I-T raid The domestic pharma market has grown at a better pace of 9.2% year on year in December 2023, after a poor show of just 2.9% year-on-year growth in November 2023, said analysts at Elara Securities India private Ltd referring to data by Pharmatrac, a pharmaceuticals market research company. The Chronic segment of drugs continue to drive the growth in the Indian pharma market. The acute segment of drugs had seen tepid growth in November too, which is attributed to the seasonal factors.

Health Minister Mark Holland reiterated on Wednesday that there is “no way” Florida, or any other foreign jurisdiction, will be allowed to threaten Canada’s drug supply.

turnover in the next three years and has launched the 'Molecule initiative' with an aim to become the world's foremost pain management company. The company is also targeting to propel itself from 56th position to the top 20 pharmaceutical companies in India in the next three years, a statement said.

Sectorally, buying was seen in consumer durables, infrastructure, healthcare, IT and metal stocks while public sector, oil & gas, FMCG and utilities saw some selling pressure. Stocks that were in focus on Wednesday include names like Network18 Media & Investment, which was up 20%, Cochin Shipyard which hit a fresh record high and closed with gains of 20% and GlaxoSmithKline Pharmaceuticals which rose more than 5%. We have collated a list of three stocks that either hit a fresh 52-week high, or an all-time high or saw a volume or a price breakout. We spoke to an analyst on how one should look at these stocks the next trading day entirely from an educational point of view. Here’s what Anand James, chief market strategist, Geojit Financial Services, had to say:

Shares of GlaxoSmithKline Pharmaceuticals Ltd.(up 5.5 per cent), Cipla Ltd.(up 3.09 per cent), Abbott India Ltd.(up 1.55 per cent), Ipca Laboratories Ltd.(up 1.19 per cent) and Sanofi India Ltd.(up 1.02 per cent) ended the day as top gainers in the pack. On the other hand, Divi's Laboratories Ltd.(down 2.05 per cent), Gland Pharma Ltd.(down 1.66 per cent), Granules India Ltd.(down 1.43 per cent), Laurus Labs Ltd.(down 1.28 per cent) and Alkem Laboratories Ltd.(down 1.13 per cent) finished as the top losers of the day.

Health Canada on Monday emphasized its commitment to taking swift action to “safeguard” the country’s prescription drug supply after a U.S. ruling that could see certain drugs imported south of the border from Canada.The warning comes days after the U.S.

IPO, which will be launched later this month. The SME IPO will include a fresh equity issue of 41 lakh shares. Beeline Capital Advisors is the book-running lead manager, and Skyline Financial Services is the registrar of the issue. The Mumbai-headquartered EPC contractor specialises in delivering full-scale project management, procurement support and comprehensive engineering services for various electrical infrastructure, instrumentation, and automation projects across India and abroad. Its services are applicable in several manufacturing industries, such as oil & gas, refinery, steel, cement, pharmaceuticals, textiles, hospitals, and health care, both domestically and internationally. Konstelec Engineers has a strong order book of over 50 major projects worth around Rs 565 crore in order value that are in various phases of implementation. The company’s ongoing projects include electrical, construction power work and instrumentation work for leading corporates such as JSW Vijayanagar Metallics Ltd, Rajasthan Refinery Project, HRRL Pachpadra, Mangalore Terminal Expansion Project, Karnataka State and Benue Cement Plant in Nigeria. The company counts leading corporate conglomerates, including Reliance Industries, Engineers India, JSW Steel, Indian Oil, BPCL, among others as its clientele. Majority of the funds raised will be used to meet the working capital expenses for procuring high-quality products for its long-term projects and to provide collateral security to various clients. «Our robust order book and long-standing client relationships demonstrate our dedication to delivering high-quality, safe and innovative solutions,» said Biharilal Ravilal Shah, chairman and managing director of Konstelec Engineers. In

(Reuters) -Regeneron Pharmaceuticals on Monday reported eye drug Eylea's fourth-quarter preliminary U.S. sales below Wall Street expectations, as the company's blockbuster product faced pressure from a rival.

pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on Saturday, although small companies have asked for a delay, citing their debt load. Jolted by a string of overseas deaths linked to Indian-made drugs since 2022, Prime Minister Narendra Modi's government has stepped up scrutiny of pharmaceutical factories to clean up the image of the $50 billion industry. «The manufacturer must assume responsibility for the quality of the pharmaceutical products to ensure that they are fit for their intended use, comply with the requirements of the licence and do not place patients at risk due to inadequate safety, quality or efficacy,» said the notification, dated Dec. 28. Companies must market a finished product only after getting «satisfactory results» on tests of the ingredients and retain a sufficient quantity of the samples of intermediate and final products to allow repeated testing or verification of a batch, it says. The health ministry said in August that inspections of 162 drug factories since December 2022 found an «absence of testing of incoming raw materials».